Unethical pharmaceutical marketing: a common problem requiring collective responsibility
Shai Mulinari and Piotr Ozieranski argue healthcare professionals and organisations should respond more forcefully to unethical marketing and support stronger regulatory action The marketing practices used by pharmaceutical companies have been a longstanding concern,12 with controversial techniques including the use of medical opinion leaders and third parties such as patient advocacy groups. In many jurisdictions, including Europe,3 Japan,4 Canada,5 and Australia,6 marketing by pharmaceutical companies is largely regulated by the industry itself, based on codes of practice drawn up by nationa...
Source: bmj.com
